Boeri miRNA signature of risk for lung cancer
Aliases:This biomarker is also known as:
miRNA expression analyses in plasma samples collected 1−2 y before the onset of disease, at the time of CT detection and in disease-free smokers enrolled in the screening trial, resulted in the generation of miRNA signatures with strong predictive, diagnostic, and prognostic potential (area under the ROC curve ≥ 0.85). The signature of risk for lung cancer is comprised of 16 ratios composed from 15 miRNAs: 140-5p, 660, 320, 28-3p, 451, 92a, 197, 221, 19b, 142-3p, 15b, 30c, 30b, 17, 106a.
|QA State:||Under Review|
There are no datasets associated with this biomarker.